全球頸動脈支架市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計頸動脈支架市場將從 2025 年的 6.6464 億美元成長到 2034 年的 9.1057 億美元，2026 年至 2034 年的複合年成長率為 3.56%。

隨著全球心血管疾病和中風發病率的上升，全球頸動脈支架市場正穩定成長。頸動脈置入術是一種微創手術，用於治療頸動脈狹窄和預防中風。人們對微創手術技術的日益青睞以及患者預後的改善推動了該技術的普及。支架設計和影像導引系統的技術進步進一步提高了手術的安全性和有效性。

人口老化、久坐的生活方式以及高血壓和高膽固醇盛行率的上升是推動心血管疾病成長的成長要素。醫療機構正著重強調早期診斷和預防性心血管治療。生物相容性材料和栓塞預防裝置的改進正在提升臨床療效。此外，已開發國家醫療基礎設施的擴建和醫療政策的完善也促進了先進支架置入術的應用。

展望未來，得益於新一代藥物釋放型支架的創新和導管系統的改進，預計市場將保持強勁成長。在新興市場，隨著人們對心臟疾病的認知不斷提高以及心臟治療設施的擴建，預計將迎來成長機會。正在進行的臨床試驗和先進醫療設備的監管核准將進一步刺激市場需求。由於預防中風仍然是醫療保健的重中之重，頸動脈支架市場預計將繼續保持其全球持續成長的勢頭。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球頸動脈支架市場：依類型分類

• 市場分析、洞察與預測
• 藥物釋放型支架
• 裸金屬支架
• 生物可吸收支架

第5章 全球頸動脈支架市場：依材料分類

• 市場分析、洞察與預測
• 金屬
• 聚合物

第6章：全球頸動脈支架市場：依輸送方式分類

• 市場分析、洞察與預測
• 球囊擴張型支架
• 自動擴張型支架

第7章 全球頸動脈支架市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第8章 全球頸動脈支架市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories Inc
  • Balton Sp Z OO
  • Boston Scientific Corporation
  • Cordis
  • InspireMD Inc
  • Medtronic Plc
  • Terumo Europe NV
  • MicroPort Scientific Corporation
  • Silk Road Medical Inc
  • Cardinal Health Inc

The Carotid Artery Stents Market size is expected to reach USD 910.57 Million in 2034 from USD 664.64 Million (2025) growing at a CAGR of 3.56% during 2026-2034.

The Global Carotid Artery Stents Market is growing steadily due to the rising incidence of cardiovascular diseases and stroke worldwide. Carotid artery stenting is a minimally invasive procedure used to prevent stroke by treating carotid artery stenosis. Increasing preference for minimally invasive surgical techniques and improved patient outcomes are driving adoption. Technological advancements in stent design and imaging guidance systems further enhance procedural safety and effectiveness.

Key growth drivers include aging populations, sedentary lifestyles, and increasing hypertension and cholesterol levels. Healthcare providers are emphasizing early diagnosis and preventive cardiovascular treatments. Improvements in biocompatible materials and embolic protection devices have strengthened clinical outcomes. Additionally, expanding healthcare infrastructure and reimbursement policies in developed economies are supporting the adoption of advanced stenting procedures.

Future prospects indicate strong growth with innovation in next-generation drug-eluting stents and improved catheter systems. Emerging markets are expected to offer growth opportunities due to rising awareness and expanding cardiac care facilities. Continuous clinical research and regulatory approvals for advanced devices will further stimulate demand. As stroke prevention remains a healthcare priority, the carotid artery stents market is likely to experience sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

By Material

• Metals
• Polymers

By Mode of Delivery

• Balloon-expandable Stents
• Self-expanding Stents

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories Inc, Balton Sp z oo, Boston Scientific Corporation, Cordis, InspireMD Inc, Medtronic plc, Terumo Europe NV, MicroPort Scientific Corporation, Silk Road Medical Inc, Cardinal Health Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CAROTID ARTERY STENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bare Metal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CAROTID ARTERY STENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Metals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Polymers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CAROTID ARTERY STENTS MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. Balloon-expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Self-expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CAROTID ARTERY STENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CAROTID ARTERY STENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Material
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Material
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Material
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Material
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Material
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CAROTID ARTERY STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories Inc
  • 10.2.2 Balton Sp Z O.O
  • 10.2.3 Boston Scientific Corporation
  • 10.2.4 Cordis
  • 10.2.5 InspireMD Inc
  • 10.2.6 Medtronic Plc
  • 10.2.7 Terumo Europe NV
  • 10.2.8 MicroPort Scientific Corporation
  • 10.2.9 Silk Road Medical Inc
  • 10.2.10 Cardinal Health Inc